38 related articles for article (PubMed ID: 4228296)
1. A rare case of nitrofurantoin-induced acute lung injury.
Karmali R; Stawitzky K; Srisethnil I; Simpson K
Clin Case Rep; 2020 Oct; 8(10):2029-2033. PubMed ID: 33088545
[TBL] [Abstract][Full Text] [Related]
2. [Hypersensitivity reactions of the lung to nitrofurantoin].
Müller U; Abbühl K; Bisig J; Baumgartner H; Mühlberger F; Scherrer M; Hoigné R
Schweiz Med Wochenschr; 1970 Dec; 100(51):2206-12. PubMed ID: 5525043
[No Abstract] [Full Text] [Related]
3. Nitrofurantoin lung sensitivity: report of a case with prolonged nitrofurantoin lymphocyte sensitivity and interaction of nitrofurantoin-stimulated lymphocytes with alveolar cells.
Pearsall HR; Ewalt J; Tsoi MS; Sumida S; Backus D; Winterbauer RH; Webb DR; Jones H
J Lab Clin Med; 1974 May; 83(5):728-37. PubMed ID: 4595420
[No Abstract] [Full Text] [Related]
4. [Pulmonary manifestations of nitrofurantoin allergy].
Wiontzek H
Prax Pneumol; 1970 Jan; 24(1):20-3. PubMed ID: 5415902
[No Abstract] [Full Text] [Related]
5. [Pulmonary toxicity resulting from the use of nitrofurantoin].
Broes MJ; Roelofs BF; Mudde AH; Hoornenborg E
Ned Tijdschr Geneeskd; 2012; 156(44):A4990. PubMed ID: 23114172
[TBL] [Abstract][Full Text] [Related]
6. Allergic pulmonary complications during treatment with nitrofurantoin.
Jameson S
Scand J Urol Nephrol; 1969; 3(1):50-2. PubMed ID: 5351895
[No Abstract] [Full Text] [Related]
7. Allergic pulmonary infiltrates probably due to nitrofurantoin.
DeMasi CJ
Arch Intern Med; 1967 Nov; 120(5):631-4. PubMed ID: 4228296
[No Abstract] [Full Text] [Related]
8. Nitrofurantoin in urinary tract infections. I. Nitrofurantoin revisited.
Holloway WJ
Del Med J; 1972 Apr; 44(4):99-104. PubMed ID: 4554908
[No Abstract] [Full Text] [Related]
9. [Drug-induced lung diseases].
Medici TC; Fontana A
Schweiz Med Wochenschr; 1977 Feb; 107(6):162-71. PubMed ID: 13491
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary toxicity of nitrofurantoin.
Witten CM
Arch Phys Med Rehabil; 1989 Jan; 70(1):55-7. PubMed ID: 2644915
[TBL] [Abstract][Full Text] [Related]
11. [Nitrofurantoïne, recommendations to be followed to reduce severe complications occurency risk].
Renard C; Laigneau MA; Renaudineau E
Presse Med; 2016 Mar; 45(3):369-71. PubMed ID: 26868527
[No Abstract] [Full Text] [Related]
12. Reappraisal of the risk/benefit of nitrofurantoin: review of toxicity and efficacy.
Shah RR; Wade G
Adverse Drug React Acute Poisoning Rev; 1989; 8(4):183-201. PubMed ID: 2694823
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
